Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Progyny, Inc.PGNY · Entity 4521 | Director · Executive Chairman | January 02, 2026 | January 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Progyny, Inc.
Report date January 02, 2026 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 238,462 |
Reported balance
After 2026-01-02 transaction · row 1
1 source rowRow 1 · 2026-01-02 · Tax withholding · Disposed 2,171 · Balance 238,462 F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 04, 2022 Filed Nov 7, 2022 21:13 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 25,020 | $0.91 | $22,768.20 |
DisclosureSEC source: 0001628280-22-028641 · wf-form4_166785557641664.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,568 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 21:13 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,500 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-22-028641 · wf-form4_166785557641664.xml · derivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,266,846 Underlying: Common Stock · 8,500 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 21:13 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 8,500 | $39.19 | $333,115.00 |
DisclosureSEC source: 0001628280-22-028641 · wf-form4_166785557641664.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,548 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.12 to $39.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 21:13 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 8,500 | $0.91 | $7,735.00 |
DisclosureSEC source: 0001628280-22-028641 · wf-form4_166785557641664.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,048 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 20:10 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 41,667 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-22-028189 · wf-form4_166750620424995.xml · derivative · entry 11 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,275,346 Underlying: Common Stock · 41,667 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 20:10 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 300 | $43.68 | $13,104.00 |
DisclosureSEC source: 0001628280-22-028189 · wf-form4_166750620424995.xml · nonDerivative · entry 9 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,548 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 20:10 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 8,517 | $42.56 | $362,483.52 |
DisclosureSEC source: 0001628280-22-028189 · wf-form4_166750620424995.xml · nonDerivative · entry 8 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,848 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.25 to $43.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 20:10 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 15,683 | $41.64 | $653,040.12 |
DisclosureSEC source: 0001628280-22-028189 · wf-form4_166750620424995.xml · nonDerivative · entry 7 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,365 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.24 to $42.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 20:10 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 17,167 | $40.62 | $697,323.54 |
DisclosureSEC source: 0001628280-22-028189 · wf-form4_166750620424995.xml · nonDerivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,048 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.23 to $41.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 20:10 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 41,667 | $0.91 | $37,916.97 |
DisclosureSEC source: 0001628280-22-028189 · wf-form4_166750620424995.xml · nonDerivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,215 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:10 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 41,667 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-22-028189 · wf-form4_166750620424995.xml · derivative · entry 10 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,317,013 Underlying: Common Stock · 41,667 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:10 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 200 | $45.91 | $9,182.00 |
DisclosureSEC source: 0001628280-22-028189 · wf-form4_166750620424995.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,548 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.90 to $45.91, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:10 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 5,812 | $45.00 | $261,540.00 |
DisclosureSEC source: 0001628280-22-028189 · wf-form4_166750620424995.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,748 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.72 to $45.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:10 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 35,655 | $44.08 | $1,571,672.40 |
DisclosureSEC source: 0001628280-22-028189 · wf-form4_166750620424995.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,560 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.71 to $44.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:10 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 41,667 | $0.91 | $37,916.97 |
DisclosureSEC source: 0001628280-22-028189 · wf-form4_166750620424995.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,215 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 25, 2022 Filed Oct 27, 2022 20:48 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 25,989 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-22-027229 · wf-form4_166690370759777.xml · derivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,358,680 Underlying: Common Stock · 25,989 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| October 25, 2022 Filed Oct 27, 2022 20:48 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 7,489 | $39.98 | $299,410.22 |
DisclosureSEC source: 0001628280-22-027229 · wf-form4_166690370759777.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,548 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.92 to $40.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 25, 2022 Filed Oct 27, 2022 20:48 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 18,500 | $39.48 | $730,380.00 |
DisclosureSEC source: 0001628280-22-027229 · wf-form4_166690370759777.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,037 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.91 to $39.91, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 25, 2022 Filed Oct 27, 2022 20:48 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 25,989 | $0.91 | $23,649.99 |
DisclosureSEC source: 0001628280-22-027229 · wf-form4_166690370759777.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,537 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 20, 2022 Filed Oct 24, 2022 20:13 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionOption (Right to Buy) · Derivative | 2,200 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-22-026875 · wf-form4_166664218486633.xml · derivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,384,669 Underlying: Common Stock · 2,200 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| October 20, 2022 Filed Oct 24, 2022 20:13 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 2,200 | $39.37 | $86,614.00 |
DisclosureSEC source: 0001628280-22-026875 · wf-form4_166664218486633.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,548 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.36 to $39.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote Read SEC document |
| October 20, 2022 Filed Oct 24, 2022 20:13 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 2,200 | $0.91 | $2,002.00 |
DisclosureSEC source: 0001628280-22-026875 · wf-form4_166664218486633.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,748 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 20:20 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionOption (Right to Buy) · Derivative | 32,459 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-22-026636 · wf-form4_166621077123651.xml · derivative · entry 7 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,386,869 Underlying: Common Stock · 32,459 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 20:20 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 863 | $40.43 | $34,891.09 |
DisclosureSEC source: 0001628280-22-026636 · wf-form4_166621077123651.xml · nonDerivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,548 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.40 to $40.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 20:20 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 31,596 | $39.62 | $1,251,833.52 |
DisclosureSEC source: 0001628280-22-026636 · wf-form4_166621077123651.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,411 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.37 to $40.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 20:20 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 32,459 | $0.91 | $29,537.69 |
DisclosureSEC source: 0001628280-22-026636 · wf-form4_166621077123651.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,007 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 17, 2022 Filed Oct 19, 2022 20:20 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionOption (Right to Buy) · Derivative | 1,300 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-22-026636 · wf-form4_166621077123651.xml · derivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,419,328 Underlying: Common Stock · 1,300 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| October 17, 2022 Filed Oct 19, 2022 20:20 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,300 | $39.34 | $51,142.00 |
DisclosureSEC source: 0001628280-22-026636 · wf-form4_166621077123651.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,548 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.33 to $39.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 17, 2022 Filed Oct 19, 2022 20:20 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 1,300 | $0.91 | $1,183.00 |
DisclosureSEC source: 0001628280-22-026636 · wf-form4_166621077123651.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,848 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 14, 2022 Filed Oct 17, 2022 21:02 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionOption (Right to Buy) · Derivative | 1,850 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-22-026503 · wf-form4_166603934153764.xml · derivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,420,628 Underlying: Common Stock · 1,850 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| October 14, 2022 Filed Oct 17, 2022 21:02 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,850 | $39.41 | $72,908.50 |
DisclosureSEC source: 0001628280-22-026503 · wf-form4_166603934153764.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,548 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.40 to $39.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 14, 2022 Filed Oct 17, 2022 21:02 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 1,850 | $0.91 | $1,683.50 |
DisclosureSEC source: 0001628280-22-026503 · wf-form4_166603934153764.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 13, 2022 Filed Oct 17, 2022 21:02 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionOption (Right to Buy) · Derivative | 400 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-22-026503 · wf-form4_166603934153764.xml · derivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,422,478 Underlying: Common Stock · 400 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| October 13, 2022 Filed Oct 17, 2022 21:02 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 400 | $39.46 | $15,784.00 |
DisclosureSEC source: 0001628280-22-026503 · wf-form4_166603934153764.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,548 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.44 to $39.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 13, 2022 Filed Oct 17, 2022 21:02 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 400 | $0.91 | $364.00 |
DisclosureSEC source: 0001628280-22-026503 · wf-form4_166603934153764.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,948 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 20:34 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionOption (Right to Buy) · Derivative | 56,852 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-22-026161 · wf-form4_166517484108832.xml · derivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,422,878 Underlying: Common Stock · 56,852 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 20:34 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 56,852 | $40.26 | $2,288,861.52 |
DisclosureSEC source: 0001628280-22-026161 · wf-form4_166517484108832.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,548 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.08 to $40.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 20:34 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 56,852 | $0.91 | $51,735.32 |
DisclosureSEC source: 0001628280-22-026161 · wf-form4_166517484108832.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 20:34 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionOption (Right to Buy) · Derivative | 3,950 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-22-026161 · wf-form4_166517484108832.xml · derivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,479,730 Underlying: Common Stock · 3,950 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 20:34 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 3,950 | $40.18 | $158,711.00 |
DisclosureSEC source: 0001628280-22-026161 · wf-form4_166517484108832.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,548 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.18 to $40.215, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 20:34 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 3,950 | $0.91 | $3,594.50 |
DisclosureSEC source: 0001628280-22-026161 · wf-form4_166517484108832.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,498 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2022 Filed Sep 9, 2022 20:46 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionOption (Right to Buy) · Derivative | 14,854 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-22-024697 · wf-form4_166275635442318.xml · derivative · entry 8 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,483,680 Underlying: Common Stock · 14,854 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| September 08, 2022 Filed Sep 9, 2022 20:46 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 3,400 | $42.22 | $143,548.00 |
DisclosureSEC source: 0001628280-22-024697 · wf-form4_166275635442318.xml · nonDerivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,548 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.88 to $42.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote Read SEC document |
| September 08, 2022 Filed Sep 9, 2022 20:46 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 9,954 | $41.61 | $414,185.94 |
DisclosureSEC source: 0001628280-22-024697 · wf-form4_166275635442318.xml · nonDerivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,948 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.85 to $41.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote Read SEC document |
| September 08, 2022 Filed Sep 9, 2022 20:46 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,500 | $40.27 | $60,405.00 |
DisclosureSEC source: 0001628280-22-024697 · wf-form4_166275635442318.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,902 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.73 to $40.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote Read SEC document |
| September 08, 2022 Filed Sep 9, 2022 20:46 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 14,854 | $0.91 | $13,517.14 |
DisclosureSEC source: 0001628280-22-024697 · wf-form4_166275635442318.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 07, 2022 Filed Sep 9, 2022 20:46 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionOption (Right to Buy) · Derivative | 67,779 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-22-024697 · wf-form4_166275635442318.xml · derivative · entry 7 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,498,534 Underlying: Common Stock · 67,779 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| September 07, 2022 Filed Sep 9, 2022 20:46 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 67,779 | $39.46 | $2,674,559.34 |
DisclosureSEC source: 0001628280-22-024697 · wf-form4_166275635442318.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,548 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.44 to $39.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 07, 2022 Filed Sep 9, 2022 20:46 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 67,779 | $0.91 | $61,678.89 |
DisclosureSEC source: 0001628280-22-024697 · wf-form4_166275635442318.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,327 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2022 Filed Sep 6, 2022 20:21 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionOption (Right to Buy) · Derivative | 700 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-22-024366 · wf-form4_166249570016850.xml · derivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,566,313 Underlying: Common Stock · 700 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.